Investor Suit Over Alleged Parkinson’s Disease Drug Misstatements Dismissed
SAN DIEGO — Ruling that the lead plaintiff in a securities class action against a drug company and several of its current and former senior executives has three times failed to...To view the full article, register now.
Already a subscriber? Click here to view full article